Fucose Binding Cancels out Mechanical Differences between Distinct Human Noroviruses.
AFM
mechanical properties
nanoindentation
norovirus-like particles (noroVLPs)
virus-ligand interaction
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
30 06 2023
30 06 2023
Historique:
received:
17
04
2023
revised:
20
06
2023
accepted:
26
06
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
The majority of nonbacterial gastroenteritis in humans and livestock is caused by noroviruses. Like most RNA viruses, frequent mutations result in various norovirus variants. The strain-dependent binding profiles of noroviruses to fucose are supposed to facilitate norovirus infection. It remains unclear, however, what the molecular mechanism behind strain-dependent functioning is. In this study, by applying atomic force microscopy (AFM) nanoindentation technology, we studied norovirus-like particles (noroVLPs) of three distinct human norovirus variants. We found differences in viral mechanical properties even between the norovirus variants from the same genogroup. The noroVLPs were then subjected to fucose treatment. Surprisingly, after fucose treatment, the previously found considerable differences in viral mechanical properties among these variants were diminished. We attribute a dynamic switch of the norovirus P domain upon fucose binding to the reduced differences in viral mechanical properties across the tested norovirus variants. These findings shed light on the mechanisms used by norovirus capsids to adapt to environmental changes and, possibly, increase cell infection. Hereby, a new step towards connecting viral mechanical properties to viral prevalence is taken.
Identifiants
pubmed: 37515170
pii: v15071482
doi: 10.3390/v15071482
pmc: PMC10383637
pii:
doi:
Substances chimiques
Fucose
28RYY2IV3F
Capsid Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12828-12832
pubmed: 31182604
PLoS Pathog. 2020 Jul 2;16(7):e1008619
pubmed: 32614892
Nano Lett. 2011 Nov 9;11(11):4865-9
pubmed: 21967663
Science. 1999 Oct 8;286(5438):287-90
pubmed: 10514371
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7600-5
pubmed: 15133147
Virology. 2015 Sep;483:203-8
pubmed: 25980740
Viruses. 2019 Mar 08;11(3):
pubmed: 30857192
J Virol. 1992 Nov;66(11):6527-32
pubmed: 1328679
Methods Mol Biol. 2019;1886:259-278
pubmed: 30374873
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul;12(4):e1613
pubmed: 31960585
J Virol. 2012 Jan;86(1):284-92
pubmed: 22031945
Nat Commun. 2022 Mar 10;13(1):1241
pubmed: 35273142
Mol Cell Proteomics. 2010 Aug;9(8):1742-51
pubmed: 20418222
Mass Spectrom Rev. 2004 Sep-Oct;23(5):368-89
pubmed: 15264235
J Clin Microbiol. 2007 Apr;45(4):1347-9
pubmed: 17267629
Science. 2016 Aug 26;353(6302):933-6
pubmed: 27540007
Nat Commun. 2020 Jun 2;11(1):2759
pubmed: 32488028
J Phys Condens Matter. 2018 Feb 14;30(6):064006
pubmed: 29282349
J Gen Virol. 2019 Oct;100(10):1393-1406
pubmed: 31483239
Molecules. 2021 Apr 07;26(8):
pubmed: 33917179
J Virol. 2012 Apr;86(7):3635-46
pubmed: 22278249
Transfusion. 2013 Oct;53(10 Pt 2):2422-30
pubmed: 23782012
Anal Chem. 2006 Nov 1;78(21):7473-83
pubmed: 17073415
J Gen Virol. 2010 Oct;91(Pt 10):2449-56
pubmed: 20592107
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9175-80
pubmed: 18599458
Methods Mol Biol. 2019;1886:243-257
pubmed: 30374872
Adv Virus Res. 2019;105:189-238
pubmed: 31522705
J Am Soc Mass Spectrom. 2017 Jan;28(1):5-13
pubmed: 27909974
Biochem Soc Trans. 2022 Feb 28;50(1):347-359
pubmed: 34940787
Nat Rev Microbiol. 2016 Jul;14(7):421-33
pubmed: 27211790
Glycobiology. 2013 Mar;23(3):276-85
pubmed: 23118206
Nat Commun. 2019 Mar 21;10(1):1320
pubmed: 30899001
Rev Med Virol. 2019 Jan;29(1):e2019
pubmed: 30411832
Science. 1990 Dec 14;250(4987):1580-3
pubmed: 2177224
Trends Microbiol. 2005 Jun;13(6):285-93
pubmed: 15936661
Viruses. 2019 May 30;11(6):
pubmed: 31151248
Euro Surveill. 2015 Jul 02;20(26):
pubmed: 26159308
Clin Infect Dis. 2000 Sep;31(3):739-51
pubmed: 11017824
Lancet Infect Dis. 2014 Aug;14(8):725-730
pubmed: 24981041
J Mol Biol. 2008 May 30;379(2):385-96
pubmed: 18448123
Arch Virol. 2005 Jan;150(1):21-36
pubmed: 15449145
Front Bioeng Biotechnol. 2015 Jul 30;3:103
pubmed: 26284238
ACS Nano. 2020 Apr 28;14(4):3822-3835
pubmed: 32223179
Virology. 2015 Feb;476:386-394
pubmed: 25591173